1217654-48-2 Usage
Description
(2S,4R)-4-(4-bromobenzyl)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid is a chiral pyrrolidine derivative featuring a pyrrolidine ring with a carboxylic acid and a tert-butoxycarbonyl group attached to it, as well as a 4-bromobenzyl group. The (2S,4R) configuration indicates the orientation of its stereocenters, making it a unique and potentially reactive molecule in the field of organic synthesis and drug discovery.
Uses
Used in Organic Synthesis:
(2S,4R)-4-(4-bromobenzyl)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid is used as a building block in organic synthesis for its unique structure and reactivity, allowing for the creation of various complex organic compounds.
Used in Drug Discovery:
(2S,4R)-4-(4-bromobenzyl)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid is used as a pharmaceutical intermediate or precursor in drug discovery due to its potential applications in medicinal chemistry, particularly with the presence of the bromobenzyl group that may offer specific therapeutic advantages.
Used in Medicinal Chemistry:
(2S,4R)-4-(4-bromobenzyl)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid is utilized in medicinal chemistry for the development of new pharmaceuticals, taking advantage of its structural features to target specific biological pathways or receptors.
Check Digit Verification of cas no
The CAS Registry Mumber 1217654-48-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,6,5 and 4 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1217654-48:
(9*1)+(8*2)+(7*1)+(6*7)+(5*6)+(4*5)+(3*4)+(2*4)+(1*8)=152
152 % 10 = 2
So 1217654-48-2 is a valid CAS Registry Number.
1217654-48-2Relevant articles and documents
FACTOR XIIA INHIBITORS
-
Paragraph 00363-00366, (2019/10/19)
This invention relates to compoundsof formula (I)and methods of treatment using the compounds. The invention also relates to processes and methods for producing the compounds of the invention. The compounds of the invention are modulators of Factor XII (e.g. Factor XIIa). In particular, the compounds are inhibitors of Factor XIIa and may be useful as anticoagulants.
